Erie, PANCT05802329Now EnrollingIRB Ready

Center Involved Diabetic Macular Edema Clinical Trial in Erie, PA

Access cutting-edge center involved diabetic macular edema treatment through this clinical trial at a research site in Erie. Study-provided care at no cost to qualified participants.

Sponsored by Ocugen

Quick Self-Assessment

See if you qualify for this Erie location

Preparing your pre-screening questions…

Expert Care in Erie

Access center involved diabetic macular edema specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related center involved diabetic macular edema treatment provided free

Apply for This Erie Location

Check if you qualify for this center involved diabetic macular edema clinical trial in Erie, PA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Erie

    Convenient for PA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Erie site if eligible
  4. 4Begin participation

About This Center Involved Diabetic Macular Edema Study in Erie

A Phase 1 study to assess the safety and efficacy of OCU200 for center-involved diabetic macular edema

Sponsor: Ocugen

Who Can Participate

Inclusion Criteria

Diagnosis of Type 1 or Type 2 Diabetes Mellitus
Decreased visual acuity attributable primarily to DME
Central-involved DME with central retinal subfield thickness (CST) values, as assessed with spectral-domain optical coherence tomography (SD-OCT) of:
≥ 320 but ≤ 450µm if male or ≥ 305 but ≤ 435µm if female on Heidelberg Spectralis
≥ 305 but ≤ 435µm if male or ≥ 290 but ≤ 420µm if female on Zeiss Cirrus
BCVA ≤ 78 and ≥ 24 letters on ETDRS chart
Sufficient ocular media clarity, pupillary dilation and participant cooperation to permit acquisition of good quality retinal imaging
No history of prior anti-VEGF injection or history of at least 2 consecutive intravitreal anti-VEGF injection (less than 7 weeks apart) with incomplete resolution of CST within 1 year. Note: The last anti-VEGF injection must be administered at least six weeks (45 days) prior to the study treatment (Day 1) in the study eye.

Exclusion Criteria

Presence of any condition that prevent clear visualization of retina (e.g., significant cataract, vitreous hemorrhage)
Uncontrolled hypertension
Uncontrolled glaucoma
Concurrent disease in the study eye, other than central-involved DME
Intravitreal or periocular steroid treatment within 3 months prior to the screening visit
Any ocular surgery within 3 months prior to the screening visit in the study eye
Uncontrolled/poorly controlled diabetes (Glycated hemoglobin (HbA1c) ≥ 10%)
History of retinal detachment in the study eye or other retinal vascular disease in the study eye
Focal or pan-retinal laser photocoagulation in the study eye within 3 months prior to the screening visit
Presence of any inherited retinal disease or history of proliferative diabetic retinopathy
History of Renal disease including stage 3b or worse

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Erie?

Yes, this clinical trial (NCT05802329) has an active research site in Erie, PA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Center Involved Diabetic Macular Edema Treatment Options in Erie, PA

If you're searching for center involved diabetic macular edema treatment options in Erie, PA, this clinical trial (NCT05802329) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Erie research site is actively enrolling participants for this clinical trial. You'll receive care from experienced center involved diabetic macular edema specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all center involved diabetic macular edema clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Erie, PA

See all essential tremor clinical trials recruiting in Erie — not just this study.

Browse Essential Tremor Trials in Erie →

Browse More Trials by Condition

Essential Tremor TrialsType 2 Diabetes TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsDiabetic Retinopathy TrialsAll Conditions →

Ready to Join in Erie?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Erie, PA